Connect with us

Technology

Cambridge CARES continues decade-long collaboration with Singapore universities with two decarbonisation projects

Published

on

The University of Cambridge’s first overseas research centre (CARES) hosted Mr Heng Swee Keat, Deputy Prime Minister and Chairman of the National Research Foundation (NRF) to view the centre’s technical capabilities for decarbonisation research.Local and international partners will advance research on non-fossil fuel-based pathways for Singapore industries.

SINGAPORE, Dec. 5, 2024 /PRNewswire/ — The Cambridge Centre for Advanced Research and Education in Singapore (CARES) is hosting two projects under the newly launched CREATE Thematic Programme in Decarbonisation supported by the National Research Foundation (NRF). The two projects will investigate non-fossil fuel-based pathways for Singapore’s chemical manufacturing industry and energy systems. The projects will advance new technology and ideas from existing work at CARES and aid in Singapore’s business transition away from petrochemicals towards a net-zero emissions target by 2050.

Deputy Prime Minister and Chairman of the NRF, Mr Heng Swee Keat toured the first of three laboratories for the programme to view the technical capabilities required for the various project teams, including CARES’ projects on the Sustainable Manufacture of Molecules and Materials in Singapore (SM3), and Hydrogen and Ammonia Combustion in Singapore (HYCOMBS).

As part of the lab demonstrations on decarbonisation, CARES showcased an additional ongoing activity with City Energy investigating hydrogen-rich town gas for residential and commercial cooking stoves.

Prof. Alexei Lapkin (CARES), Prof. Chiba Shunsuke (NTU Singapore), Prof. Ning Yan (NUS), Assoc Prof. Ming Joo Koh (NUS), Dr. Philippe Schwaller (Swiss Federal Institute of Technology Lausanne, EPFL), and Prof. Matthew Gaunt (University of Cambridge), Principal Investigators for SM3, share a joint statement:

SM3 will provide a path to a net-zero, high-value chemical manufacturing industry in Singapore. Its core goal is to address the dependency of the producers of performance chemicals on starting materials that typically come from fossil-based carbon sources. The SM3 team will develop effective synthetic methods that best convert cheap and abundant fossil-free raw materials into high-value molecules. SM3 will transform the production of functional molecules, such as medicines and agrochemicals, creating a new value chain for the sustainable chemical industry.

Prof. Epaminondas Mastorakos (CARES), Prof. Fei Duan (NTU Singapore), Prof. Kaoru Maruta (Tohoku University), Dr Nabiha Chaumeix (CNRS France), Asst Prof Zhang Huangwei (NUS), Principal Investigators for HYCOMBS, share a joint statement:

In the near future, Singapore may adopt hydrogen or ammonia as a possible carbon-free fuel for decarbonisation; however, this requires the development of new gas turbines and internal combustion engines. In project HYCOMBS, universities from Singapore, UK, Japan, France and Norway will work together to investigate the underlying combustion process of hydrogen and ammonia to minimise pollutants and accelerate industry innovation. We are grateful for the opportunity to work on this project that can transform how these zero-carbon fuels are utilised, benefiting Singaporeans and global environmental advancement.

Since 2013, CARES has been involved in research programmes with NTU and NUS as the University of Cambridge’s first overseas centre. One of its early flagship programmes, the Centre for Carbon Reduction in Chemical Technologies (C4T), has investigated areas from sustainable reaction engineering, electrochemistry, and maritime decarbonisation, to digitalisation.

By building on this foundation and leveraging the local talent pool, CARES has attracted new partners from international universities and institutes for SM3 and HYCOMBS. This includes EPFL, the Swiss Federal Institute of Technology Lausanne, which will provide skills in the domain AI for chemistry. CNRS, the French National Centre for Scientific Research, from France, the Norwegian University of Science and Technology, and Tohoku University from Japan will contribute technical equipment and key talent in hydrogen and ammonia combustion. The connection with CNRS will be further strengthened through the presence in Singapore of CNRS@CREATE – its only subsidiary abroad – which is part of the same CREATE research programme that CARES participates in.

Singapore’s compact, interconnected infrastructure, along with strong governmental support and initiatives such as the “Singapore Green Plan 2030” will provide an ideal base for rapid testing and knowledge transfer to industry. The international scope of SM3 and HYCOMBS positions Singapore as a central hub for sustainable technology development for the global economy.

View the media release by NRF on the launch of the SGD$90m Decarbonisation programme for more information on the nine projects under CREATE’s Decarbonisation Programme.

Annex A: Full list of PIs and their affiliated universities and/or institutions

About CARES

The Cambridge Centre for Advanced Research and Education (CARES) was established in 2013 as the University of Cambridge’s first overseas research centre, bringing together researchers from Cambridge, Nanyang Technological University, and the National University of Singapore as part of the CREATE (Campus for Research Excellence and Technological Enterprise) programme. The flagship programme at CARES is the Centre for Carbon Reduction in Chemical Technology (C4T) programme which focused on decarbonising Singapore’s chemical industry and expanded in recent years to include additional themes such as digital transformation, and sectors such as the maritime industry.

A further large programme began in October 2020 called the Centre for Lifelong Learning and Individualised Cognition (CLIC). CLIC brings together researchers from the University of Cambridge and NTU to focus on the science of learning. CARES is also a research partner in the Pharmaceutical Innovation Programme Singapore (PIPS), a public-private consortium that aims to develop full process automation in a laboratory to support R&D and manufacturing.

www.cares.cam.ac.uk    LinkedIn: Cambridge CARES

About CREATE (Campus for Research Excellence and Technological Enterprise)

CREATE is an international collaboratory housing research centres set up by top universities. At CREATE, researchers from diverse disciplines and backgrounds work closely together to perform cutting-edge research in strategic areas of interest, for translation into practical applications leading to positive economic and societal outcomes for Singapore. The interdisciplinary research centres at CREATE focus on four areas of interdisciplinary thematic areas of research, namely human systems, energy systems, environmental systems and urban systems.

More information on the CREATE programme can be obtained from www.create.edu.sg.

Annex A: Full list of PIs and their affiliated universities and/or institutions

Sustainable Manufacture of Molecules and Materials in Singapore (SM3)

Prof. Alexei LAPKIN (University of Cambridge), Prof. Shunsuke CHIBA (Nanyang
Technological University, Singapore), Prof. Ning YAN (National University of Singapore),
and Assoc Prof. Ming Joo KOH (National University of Singapore) are the Programme
Leads.

All other Principal Investigators are listed in alphabetical order with their universities and/or
institutions:

•         Asst Prof. Tej Salil CHOKSI (Nanyang Technological University)

•         Prof. Matthew GAUNT (University of Cambridge)

•         Prof. Saif KHAN (National University of Singapore)

•         Dr. Ewa MAREK (University of Cambridge)

•         Asst Prof. Philippe SCHWALLER (Swiss Federal Institute of Technology Lausanne)

Webpage: https://www.cares.cam.ac.uk/research/sm3/

 

Hydrogen and Ammonia Combustion in Singapore (HYCOMBS)

Prof. Epaminondas MASTORAKOS (University of Cambridge), Assoc Prof. Fei DUAN
(Nanyang Technological University, Singapore), and Prof. Kaoru MARUTA (Tohoku
University) are the Programme Leads.

All other Principal Investigators are listed in alphabetical order with their universities and/or
institutions:

•         Prof. Siew Hwa CHAN (Nanyang Technological University)

•         Dr. Nabiha CHAUMEIX (Centre Nationale de la Recherche Scientifique)

•         Dr. Sebastian DUCRUIX (Centre Nationale de la Recherche Scientifique)

•         Assoc Prof. Akihiro HAYAKAWA (Tohoku University)

•         Prof. Nicholas MINESI (Centre Nationale de la Recherche Scientifique)

•         Asst Prof. Youhi MORII (Tohoku University)

•         Prof. Hisashi NAKAMURA (Tohoku University)

•         Prof. Christine ROUSSELLE (Centre Nationale de la Recherche Scientifique)

•         Prof. Nedunchezhian SWAMINATHAN (University of Cambridge)

•         Prof. Nicholas WORTH (Norwegian University of Science and Technology)

•         Asst Prof. Huangwei ZHANG (National University of Singapore)

 

Webpage: https://www.cares.cam.ac.uk/research/hycombs/ 

 

 

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/cambridge-cares-continues-decade-long-collaboration-with-singapore-universities-with-two-decarbonisation-projects-302323319.html

SOURCE Cambridge Centre for Advanced Research and Education in Singapore

Continue Reading

Technology

Harlem Children’s Zone Acquires FinTech Platform, Goalsetter, to Accelerate Universal Economic Mobility

Published

on

By

Acquisition combines HCZ’s proven model with Goalsetter’s innovative financial education technology to expand access and impact at scale

NEW YORK, Oct. 22, 2026 /PRNewswire/ — Today, Harlem Children’s Zone (HCZ), one of the nation’s leading anti-poverty organizations, announced the acquisition of Goalsetter, a financial technology platform that delivers best-in-class, engaging, technology-enabled learning experiences for people seeking to enhance their financial know-how, capabilities, and confidence.   

The acquisition marks a significant step in HCZ’s Wealth Builds–Universal Economic Mobility (WB-UEM) strategy, a national framework designed to help children and families build long-term economic security through cradle-to-career supports, financial education and experiences, and direct access to capital via a Child Capital Stack of asset boosts.

“We know that economic mobility is a two-generation challenge,” says Harlem Children’s Zone CEO Kwame Owusu-Kesse. “With this acquisition, we are solving for a critical component of Universal Economic Mobility by melding a proven financial education platform and HCZ’s decades of experience providing people with the knowledge and tools to build strong futures for themselves and their families. This is more than an investment in financial education. It is an investment in critical national infrastructure for economic mobility.”

Harlem Children’s Zone has decades of experience driving outcomes at scale, beginning as a one-block pilot, expanding to over 100 blocks in Central Harlem, and now working with over 70 communities across the United States. HCZ seeks to use its learnings, decades of experience driving outcomes at scale, and renowned best practices to provide pathways to economic mobility for all of America’s children and families.

“Goalsetter was built on the belief that everyone should have access to the financial knowledge and tools that can shape their future and livelihood,” said Tanya Van Court, Chief FinTech Officer at Harlem Children’s Zone and Founder of Goalsetter. “Joining Harlem Children’s Zone gives us an extraordinary opportunity to build on that work. Together, we can continue enhancing the platform, expand access for learners of all ages and walks of life, and demonstrate what is possible when mission, innovation, and technology come together to serve the most people.”

Goalsetter creates opportunities to deliver high-quality, developmentally appropriate and culturally relevant financial education with extensive reach,  including to low-income and rural communities that have historically had limited access to these resources. Its current offerings include Goalsetter Classroom, which provides standards-aligned financial education curriculum for middle and high school students, and MoneyLingo, a mobile-first financial education experience for college-aged students and adults in the workforce, covering practical topics such as saving, investing, credit, debt, and financial decision-making.                                                         

“This acquisition sends an important signal to the field,” said Owusu-Kesse. “Social impact organizations should not have to choose between mission and scale. By bringing a proven technology platform into HCZ, we’re demonstrating how non-profit organizations can be centers of business excellence, using vehicles of innovation, AI, and technology to create efficient and effective pathways to scale and impact. This acquisition strengthens our in-house capacity to build, innovate, and continuously improve outcomes.”

The organization plans to build upon Goalsetter’s existing offerings by exploring financial education products for younger learners and creating opportunities to establish a continuous financial learning journey from early childhood through adulthood.

“This is ultimately about extending opportunity to all,” added Owusu-Kesse. “By connecting financial education, technology, family engagement, and access to assets, we can help create more accessible pathways to economic mobility.”

Services to current Goalsetter clients will be unaffected by this acquisition.

View original content:https://www.prnewswire.com/news-releases/harlem-childrens-zone-acquires-fintech-platform-goalsetter-to-accelerate-universal-economic-mobility-302917320.html

SOURCE Harlem Children’s Zone

Continue Reading

Technology

Common Ground in the Battlegrounds? Surveys Reveal Widespread Bipartisan Agreement in 11 Competitive States and 28 Congressional Districts, as Well as Nationally

Published

on

By

Bipartisan Majorities Say If Congress Were to Listen to the People More, They Would More Likely Find Common Ground

COLLEGE PARK, Md., Oct. 22, 2026 /PRNewswire/ — The Program for Public Consultation (PPC) conducted extensive surveys in competitive states and congressional districts, as well as nationally, revealing a remarkable level of bipartisan common ground.

Majorities of both Democrats and Republicans agreed on: 

106 policies nationally 82 policies in all states and districts surveyed101 policies in at least two-thirds of all the states and districts surveyed

Over 40,000 Americans were surveyed in two waves with representative samples of 600-2,016 in each of the 11 competitive states surveyed, and 400-592 in each of the 28 competitive congressional districts surveyed, and 1,200-2,509 nationwide.

Nearly all policy questions were based on congressional legislation or executive branch proposals. 

Fourteen policy topics were covered: Artificial Intelligence, Housing, Healthcare, Low-Income Assistance, Families and Children, Social Security, Immigration, Abortion and Birth Control, Energy and Environment, Federal Taxes, Campaign Finance, Government Reform, Criminal Justice and America’s Role in the World. For every topic, most policies had bipartisan agreement across every battleground surveyed.

The policy questions used in these national and battleground surveys were chosen because they elicited bipartisan support in previous in-depth national surveys conducted by PPC, in which respondents received briefings on the topic and evaluated pro and con arguments for the proposed policy.

Steven Kull, director of PPC, comments, “What is striking here is that these surveys revealed widespread bipartisan agreement on over a dozen key issues that Congress has failed to resolve, from costs of healthcare, to risks of artificial intelligence, to Social Security’s impending insolvency, and many more. Clearly, there is far more common ground among the American people than there is in Congress.”

Americans Think Public Opinion Should Have More Influence
Respondents were also asked about the role of public opinion in policymaking. Across the battlegrounds, on average, respondents estimated that federally elected officials make the same decisions that the majority of Americans would make just 35% of the time.

Large majorities believe polarization in government comes not from the American people but from elected officials, and that more influence for the people would help break the logjam in Congress (Democrats 62 to 88%, Republicans 66 to 89%).

Perhaps most germane, overwhelming majorities of Democrats and Republicans in the battlegrounds believe that if members of Congress were more influenced by the people, they would be more likely to find common ground (Democrats 82 to 97%, Republicans 80 to 95%), and better serve the common good (Democrats 77 to 94%, Republicans 79 to 94%).

Steven Kull adds, “On the basis of this study, it does appear that the public is correct that if the people had more influence, Congress would be more likely to find common ground, and thus  function better.”

Americans also say that public opinion should play a substantial role in news reporting about policy. Over two-thirds say news reports on policy matters should include public opinion data most of the time or always when reliable information is available (Democrats 71 to 88%, Republicans 67 to 89%). Similarly, when Congress is about to vote on a law, large numbers say it is very or extremely important for news outlets to report whether a majority of Americans favor or oppose it (Democrats 65 to 84%, Republicans 60 to 85%).

MORE INFORMATION

Battlegrounds Common Ground SheetIndividual State and District Results, Questionnaires and MethodologiesNational Questionnaire with Toplines, Crosstabs and Methodology

About the Surveys
The state and district surveys used for this analysis were fielded July 21 – August 17, 2026, to a total of 19,949 adults, and May 27 – July 1, 2026, to 19,564 adults. They included 600-2016 in each of the 11 states, and 400-592 in each of the 28 congressional districts. Response rates ranged from 7.1 to 9.0%. Confidence intervals range from +/- 2.9 to 8.1%, and maximum weights range from 1.9 to 10.0.

The national surveys were fielded February 11-26, 2026, with 2,509 adults, and March 11-19, 2026, with 1,200 adults. The response rates were 7.6% and 8.3%, respectively. The confidence interval is +/- 2.9% for both surveys, and the maximum weights are 2.5 and 1.9.

The sample was obtained from multiple online opt-in panels, including Cint, Dynata and Prodege. Sample collection and quality control were managed by QuantifyAI under the direction of the Program for Public Consultation. The surveys were offered in both English and Spanish.

The samples were pre-stratified and weighted by age, race, ethnicity, gender, education, household income, marital status, and home ownership to match the general adult population. The national sample was further weighted by Census region. The distribution of partisan affiliation was within expectations, based on voter registration data for non-leaners and/or Cook’s Partisan Voting Index for leaners, or weighted to reflect those benchmarks.

About the Common Ground in the Battlegrounds? Survey Series
This effort aims to identify bipartisan common ground in competitive states and districts across the nation. The project seeks to educate the public, policymakers and candidates about the findings; and provide journalists with independent, nonpartisan research that brings the public into the conversation about public policy.

In addition to PPC, project partners include the Civic Innovation Center at the University of Maryland (CivIC) and Voice of the People (VOP), a national nonpartisan organization seeking to give the public a greater voice in government. None of these entities advocate for policy positions or endorse candidates.

States surveyed: Alaska; Georgia; Iowa; Maine; Michigan; Minnesota; Montana; Nebraska; New Hampshire; North Carolina; Ohio; and Texas.

Congressional Districts surveyed: Arizona’s 1st and 6th; Colorado’s 8th; Iowa’s 1st, 2nd, 3rd and 4th; Maine’s 2nd; Michigan’s 4th, 7th, 8th and 10th; Montana’s 1st; Nebraska’s 2nd; Nevada’s 3rd; New Jersey’s 7th and 9th; New Mexico’s 2nd; New York’s 3rd, 4th, 17th and 19th; Oregon’s 5th; Pennsylvania’s 1st, 7th, 8th and 10th; and Washington’s 3rd.

The survey series excluded several competitive districts because they were in states that had recently been redistricted and thus had no Census data yet to use for demographic benchmarks.

Program for Public Consultation
The Program for Public Consultation (PPC), affiliated with the University of Maryland’s School of Public Policy, seeks to improve democratic governance by consulting the public and bringing the people’s views into the public discourse. It conducts surveys with representative samples on policies proposed by elected officials and shares its findings with government officials, the media, other academics, and the general public.

Civic Innovation Center
The Civic Innovation Center (CivIC) at the University of Maryland’s School of Public Policy works to strengthen the foundations of civic health. It contributes to important debates about civic education, civic engagement, and needed democratic reforms in the state of Maryland and nationwide, in partnership with other BIG 10 universities. It works to build the connective tissue that brings together students, scholars and practitioners to help elevate the UMD community’s contribution to our wider democracy.

Voice of the People
Voice of the People (VOP) is a nonpartisan organization working to re-anchor our democracy in its founding principles by giving ‘We the People’ a greater and more effective voice in government. It champions innovative methods and technology that enable the American people to play a role in the policymaking process and provide policymakers with a more accurate understanding of the views of their constituents.

Contact: Jonathan Casaverde, jonathan.casaverde@wardcirclestrategies.com,(786) 469-9422

View original content to download multimedia:https://www.prnewswire.com/news-releases/common-ground-in-the-battlegrounds-surveys-reveal-widespread-bipartisan-agreement-in-11-competitive-states-and-28-congressional-districts-as-well-as-nationally-302915872.html

SOURCE Program for Public Consultation

Continue Reading

Technology

FDA grants 510(k) clearance for BoneEnhance, the first machine learning layer on RIVANNA’s Accuro XV platform

Published

on

By

Anatomy segmentation and three-dimensional skeletal visualization arrive with this clearance; an injury detection module for clinical decision support is in development on the platform roadmap

CHARLOTTESVILLE, Va., Oct. 22, 2026 /PRNewswire/ — RIVANNA®, developer of AI-enabled clinical decision-support solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for BoneEnhance®, a machine learning software module for the Accuro® XV diagnostic ultrasound system. The module segments bone and surrounding tissues and supports visualization of skeletal anatomy in three dimensions during image review.

The clearance moves the platform from acquisition toward interpretation. Accuro XV was cleared in April 2026 for B-mode imaging in musculoskeletal conventional and superficial applications. Its conformable three-dimensional probe automates large field-of-view image acquisition after initial patient positioning. BoneEnhance is the first machine learning software module cleared for the platform.

BoneEnhance identifies bone and surrounding tissues

Each automated acquisition creates a volumetric dataset for review. BoneEnhance identifies bone and surrounding tissues within that volume, then highlights them with color-coded overlays on the two-dimensional B-mode image. The original anatomical data remain unaltered and visible beneath the overlays. A three-dimensional indicator beside the image shows the scan orientation and the location of the displayed slice within the volume.

A platform milestone

The sequence is deliberate: decision support begins at acquisition. Accuro XV acquires the image; BoneEnhance identifies and labels the anatomy within it. Behind the integrated workflow stands a worldwide intellectual-property portfolio of more than 100 issued and pending patents across more than 20 patent families.

“We founded RIVANNA to solve a problem that cuts across care settings: decision-critical information sits outside the point-of-care workflow,” said Will Mauldin, PhD, Co-founder and CEO of RIVANNA. “BoneEnhance is where the stack begins to close that gap for musculoskeletal care: automated volumetric acquisition, now paired with cleared software-assisted review. This clearance is the foundation: the first machine learning layer, anchoring the decision-support capabilities now in development.”

Independently validated within a nationwide eight-site study

BoneEnhance was trained and validated within RIVANNA’s nationwide eight-site clinical study. Three sites contributed the training data; the other five provided the independent test set of 233 volumetric datasets, comprising 69,900 images from 173 subjects. None of the test data were used for training or tuning. Three board-certified radiologists established the reference labels, and per-volume label prediction accuracy, a measure of anatomical labeling, ranged from 95.1% to 100.0%.

Separate from the validation supporting this clearance, the platform’s automated acquisition carries peer-reviewed evidence: in a published study of 205 patients in the Journal of Emergency Medicine (DOI: 10.1016/j.jemermed.2025.11.011), operators with one hour of hands-on training acquired wrist and ankle images rated adequate for diagnostic interpretation in more than 90% of scans, with image quality comparable to physician-acquired scans.

“This clearance reflects the strength of the team RIVANNA has built across AI development, clinical affairs, and regulatory execution, and the commitment of the clinical sites that partnered with us to generate the evidence,” said Delphine Le Roux, PhD, PMP, Senior Director, Market Access and Strategic Partnerships at RIVANNA. “None of it happens without BARDA’s sustained support, which allowed us to do this the right way: rigorous, multi-site, and independent. The infrastructure, partnerships, and regulatory playbook we established for BoneEnhance are designed to carry forward. That execution engine is what positions us to pursue the next clearance with confidence.”

The next layer in development

The platform’s progression continues with an investigational musculoskeletal injury detection module. Where BoneEnhance labels the anatomy, the new module is being developed to assist clinicians in evaluating potential extremity fractures within acquired ultrasound images. The nationwide clinical study that trained and validated BoneEnhance, now expanded from eight to ten sites, is building the datasets used to train the module. Because the sites and data infrastructure were established once and are reused for each new module, every subsequent module builds on the program’s federal investment.

Federal funding acknowledgment

This project has been supported in whole or in part with federal funds from the U.S. Department of Health and Human Services; the Administration for Strategic Preparedness and Response (ASPR); Biomedical Advanced Research and Development Authority (BARDA), under contract number 75A50121C00035.

About Accuro XV

Accuro XV is a portable, small-footprint point-of-care volumetric ultrasound imaging system for musculoskeletal imaging. Its conformable three-dimensional probe automates large field-of-view B-mode image acquisition without ionizing radiation. BoneEnhance is a cleared machine learning software module available during review of Accuro XV volumetric image acquisitions. It segments bone and surrounding tissues and supports visualization of skeletal anatomy in three dimensions.

An investigational computer-aided musculoskeletal injury detection module is in development for Accuro XV. It is designed to assist clinicians in detecting extremity fractures from volumetric ultrasound and annotating soft-tissue signs associated with injury, and to support triage decisions, including referral for additional radiographic imaging.

Accuro XV is designed to provide a fracture-care layer at the point of triage, helping to streamline emergency department workflows, expedite evaluation of low-severity extremity injuries, and reduce reliance on X-ray referrals. The platform is designed to support just-in-time training to promote consistent use across clinical experience levels, advancing a shared mission to transform musculoskeletal injury care while supporting broader emergency preparedness objectives.

About RIVANNA

RIVANNA is a medical technology company developing clinical decision-support solutions powered by proprietary clinical datasets, AI models, and purpose-built imaging hardware. The company’s platform is designed to automate complex anatomical analysis at the point of care, support faster and more confident clinical decisions, reduce variability, and expand access to advanced capabilities. Its initial applications address interventional guidance and trauma triage, beginning with neuraxial procedures and musculoskeletal injury assessment. RIVANNA has established an FDA-cleared product portfolio and maintains a worldwide intellectual-property portfolio of more than 100 issued and pending patents. RIVANNA is headquartered in Charlottesville, Virginia, and operates an FDA-registered, ISO 13485:2016-certified manufacturing facility.

RIVANNA, Accuro, BoneEnhance, and the Rivanna Medical family of marks are registered and unregistered trademarks of Rivanna Medical, Inc. in the United States and other jurisdictions.

View original content to download multimedia:https://www.prnewswire.com/news-releases/fda-grants-510k-clearance-for-boneenhance-the-first-machine-learning-layer-on-rivannas-accuro-xv-platform-302917179.html

SOURCE RIVANNA

Continue Reading

Trending